Pharmacology Quiz: Acetaminophen Toxicity And Nac
20 questions · exam conditions
0:00
Acetaminophen Toxicity And NacQuestion 1 of 20

A 60 kg patient requires treatment with the 21-hour IV N-acetylcysteine protocol. The protocol specifies a loading dose of 150 mg/kg in 200 mL of D5W over 60 minutes. The pharmacy provides a stock vial of NAC with a concentration of 200 mg/mL. How many milliliters of NAC should be drawn from the stock vial to prepare the loading dose?

30 mL
45 mL
60 mL
90 mL
← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: Acetaminophen Toxicity And Nac

Practice Acetaminophen Toxicity And Nac in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Acetaminophen Toxicity And Nac, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A 60 kg patient requires treatment with the 21-hour IV N-acetylcysteine protocol. The protocol specifies a loading dose of 150 mg/kg in 200 mL of D5W over 60 minutes. The pharmacy provides a stock vial of NAC with a concentration of 200 mg/mL. How many milliliters of NAC should be drawn from the stock vial to prepare the loading dose?

  1. 30 mL
  2. 45 mL (correct answer)
  3. 60 mL
  4. 90 mL
Explanation: This is a two-step calculation:
  1. Calculate the total dose in mg: Patient weight (60 kg) × Dose (150 mg/kg) = 9000 mg of NAC.
  2. Calculate the volume of drug needed from the stock vial: Total dose (9000 mg) / Concentration (200 mg/mL) = 45 mL.
A (30 mL) would result from an incorrect calculation, possibly dividing 9000 mg by a wrong concentration of 300 mg/mL. C (60 mL) might be chosen by erroneously using the patient's weight as the volume. D (90 mL) would result from dividing the 9000 mg dose by an incorrect concentration, such as 100 mg/mL.

Question 2

A 21-year-old college student presents to the ED after ingesting 12 grams of acetaminophen simultaneously with a large quantity of vodka 4 hours ago. His blood alcohol level is 250 mg/dL. Compared to a patient who took the same dose of acetaminophen without alcohol, how does the acute co-ingestion of ethanol theoretically affect the initial phase of toxicity?

  1. It markedly increases NAPQI formation due to synergistic induction of the CYP2E1 enzyme.
  2. It accelerates the renal clearance of acetaminophen, lowering the total drug exposure.
  3. It rapidly depletes hepatic glutathione stores, increasing susceptibility to NAPQI-induced injury.
  4. It competitively inhibits CYP2E1, potentially reducing the initial peak of NAPQI formation. (correct answer)
Explanation: When you encounter acetaminophen toxicity questions involving alcohol co-ingestion, focus on the competing metabolic pathways and the concept of competitive inhibition versus chronic induction effects. Acetaminophen toxicity occurs when the normal conjugation pathways (glucuronidation and sulfation) become saturated, forcing more drug through the CYP2E1 pathway to form the toxic metabolite NAPQI. The key insight here is distinguishing between acute alcohol effects versus chronic alcohol exposure. In acute alcohol intoxication (like this scenario), ethanol and acetaminophen compete for the same enzyme system - CYP2E1. Since both substrates are present simultaneously at high concentrations, ethanol acts as a competitive inhibitor, reducing the immediate conversion of acetaminophen to NAPQI. This makes option D correct - the acute co-ingestion competitively inhibits CYP2E1, potentially reducing initial NAPQI formation. Option A is wrong because synergistic CYP2E1 induction occurs with chronic alcohol use over weeks, not acute intoxication. Option B incorrectly suggests renal mechanisms are the primary concern - acetaminophen toxicity is hepatic, and alcohol doesn't significantly enhance renal clearance. Option C confuses the timeline - while alcohol can affect glutathione stores, the immediate competitive inhibition effect on NAPQI formation is more relevant in the acute phase than glutathione depletion. Remember: acute alcohol = competitive inhibition (protective initially), chronic alcohol = enzyme induction (increased toxicity risk). This distinction frequently appears on pharmacology exams when testing drug interaction mechanisms.

Question 3

A 33-year-old female is found unconscious with an empty bottle of acetaminophen next to her. The time of ingestion is unknown. On presentation to the ED, her labs show an AST of 450 U/L and an ALT of 510 U/L. A serum acetaminophen level is pending. What is the most appropriate immediate action regarding N-acetylcysteine (NAC)?

  1. Withhold NAC until the acetaminophen level returns to accurately plot it on the nomogram.
  2. Defer treatment, as the AST/ALT elevation could be from another cause such as viral hepatitis.
  3. Administer a half-dose of NAC and await the acetaminophen level to decide on the full dose.
  4. Administer NAC immediately without waiting for the acetaminophen level. (correct answer)
Explanation: When you encounter a potential acetaminophen overdose with unknown timing and evidence of hepatotoxicity, the priority is immediate antidotal therapy. Acetaminophen poisoning follows a predictable timeline where hepatic damage becomes irreversible if treatment is delayed beyond 8-10 hours post-ingestion. The correct approach is D) Administer NAC immediately without waiting for the acetaminophen level. This patient presents with clear signs of acetaminophen-induced hepatotoxicity (elevated AST/ALT) and unknown ingestion time, making her a candidate for empirical NAC therapy. NAC works by replenishing glutathione stores and providing an alternative pathway for acetaminophen metabolism, but its effectiveness diminishes significantly with delayed administration. Option A is wrong because waiting for lab results wastes precious time when hepatocyte death may be progressing. The Rumack-Matthew nomogram is only valid for acute ingestions with known timing within 24 hours. Option B incorrectly suggests deferring treatment when the clinical picture strongly suggests acetaminophen toxicity—other causes can be investigated while providing potentially life-saving therapy. Option C represents a dangerous compromise that provides inadequate antidotal effect while still delaying optimal treatment. Remember this key principle for acetaminophen overdose management: when in doubt, treat immediately. NAC has an excellent safety profile with minimal adverse effects, making the risk-benefit ratio heavily favor early administration. The mantra "time is hepatocytes" should guide your thinking—never let uncertainty about timing or levels delay NAC in patients with evidence of acetaminophen-induced liver injury.

Question 4

A 19-year-old female presents to the emergency department 6 hours after ingesting an unknown quantity of an extended-release acetaminophen product. Her 6-hour post-ingestion serum acetaminophen level is 130 mcg/mL. According to the standard Rumack-Matthew nomogram, this level falls below the 'possible hepatic toxicity' line. What is the most appropriate next step in management?

  1. Reassure the patient and discharge home, as the serum level is below the toxic threshold.
  2. Administer a single dose of activated charcoal and observe the patient for 24 hours without further intervention.
  3. Initiate N-acetylcysteine (NAC) therapy because the nomogram is unreliable for extended-release formulations. (correct answer)
  4. Repeat the acetaminophen level in 4 hours and only start NAC if the new level plots above the nomogram line.
Explanation: The Rumack-Matthew nomogram was developed based on data from single, acute ingestions of immediate-release acetaminophen. It is not reliable for assessing risk after ingestion of extended-release (ER) products due to their prolonged and unpredictable absorption, which can lead to delayed peak serum concentrations. Standard practice is to initiate N-acetylcysteine (NAC) if the patient has ingested a potentially toxic amount of an ER product and has a measurable serum level, even if it initially plots below the nomogram line. A is incorrect because discharging the patient would be unsafe, as the level could rise into the toxic range later. B is incorrect because activated charcoal is most effective within 1-2 hours of ingestion, and observation alone is insufficient given the risk. D is incorrect because while repeating levels is part of management, delaying NAC in a confirmed ER overdose with a significant level is not recommended; treatment should be initiated promptly.

Question 5

A patient is receiving an intravenous infusion of N-acetylcysteine (NAC) 30 hours after a significant acetaminophen overdose. At this time point, liver enzymes are markedly elevated, and glutathione stores are presumed to be completely depleted. Which mechanism of NAC is most likely contributing to a therapeutic effect in this patient?

  1. Serving as a glutathione precursor to directly conjugate with newly formed NAPQI.
  2. Enhancing the non-toxic sulfation pathway for the remaining parent acetaminophen.
  3. Improving systemic hemodynamics and acting as an antioxidant to mitigate ongoing secondary liver injury. (correct answer)
  4. Stimulating the regeneration of hepatocytes through activation of growth factor signaling pathways.
Explanation: When NAC is administered late ( > 24 hours) after an overdose, significant liver injury has already occurred, and most of the parent drug has been metabolized. While its role as a glutathione precursor is primary when given early, its late benefits are attributed to other mechanisms. These include improving blood flow and oxygen delivery to the liver, scavenging reactive oxygen species to reduce secondary injury from inflammation, and modulating the immune response. A is incorrect because at 30 hours, NAPQI formation has largely ceased, so the role of NAC as a direct precursor for NAPQI conjugation is minimal. B is incorrect because the parent drug is mostly cleared by 30 hours, so enhancing alternative metabolic pathways is no longer relevant. D is incorrect because while the liver regenerates, NAC is not known to directly stimulate this process through growth factor pathways; its role is in mitigating ongoing damage.

Question 6

A patient is in Stage III of acetaminophen toxicity (72-96 hours post-ingestion). The clinical team is concerned about progression to fulminant hepatic failure. Which of the following constellations of findings is most characteristic of this stage?

  1. Peak elevation of aminotransferases with severe right upper quadrant pain.
  2. Initial symptoms of nausea, vomiting, malaise, and diaphoresis.
  3. Jaundice, coagulopathy (elevated INR), and hepatic encephalopathy. (correct answer)
  4. Complete resolution of symptoms and normalization of liver function tests.
Explanation: The clinical course of acetaminophen toxicity is divided into four stages. Stage III, occurring 72-96 hours post-ingestion, is characterized by the signs of fulminant hepatic failure. This includes jaundice (from impaired bilirubin metabolism), coagulopathy (from failed synthesis of clotting factors, reflected in a high INR), and hepatic encephalopathy (from accumulation of ammonia and other toxins). This is the period of maximum morbidity and mortality. A is incorrect as peak aminotransferase levels and RUQ pain are most characteristic of Stage II (24-72 hours). B is incorrect as these non-specific GI symptoms are characteristic of Stage I (0-24 hours). D is incorrect as this describes the recovery phase, Stage IV (4 days to 2 weeks).

Question 7

Fifteen minutes into the initial loading dose of an IV N-acetylcysteine infusion, a 22-year-old female develops flushing, pruritus, and mild urticaria. Her blood pressure and oxygen saturation remain stable. What is the most appropriate immediate action?

  1. Immediately and permanently discontinue the NAC infusion and switch to the oral formulation.
  2. Administer intramuscular epinephrine for presumed anaphylactic shock.
  3. Temporarily stop the infusion, administer diphenhydramine, and restart the infusion at a slower rate once symptoms resolve. (correct answer)
  4. Continue the infusion at the current rate but administer IV corticosteroids to prevent worsening of the reaction.
Explanation: The patient is experiencing a mild, non-IgE-mediated anaphylactoid reaction to the IV NAC infusion, which is common and related to the rate of infusion. Standard management for such a mild reaction (no hypotension or bronchospasm) is to temporarily pause the infusion, treat the symptoms with an H1-antagonist like diphenhydramine, and once the symptoms subside, resume the infusion at a slower rate (e.g., over 2 hours instead of 1). A is incorrect because the reaction is typically manageable, and permanently stopping a life-saving therapy is not warranted. B is incorrect because this is an overly aggressive response for a mild reaction without hemodynamic compromise; epinephrine is reserved for true anaphylaxis or severe anaphylactoid reactions. D is incorrect because the infusion should be stopped to reduce the causative stimulus, and antihistamines are the first-line treatment, not corticosteroids.

Question 8

A 35-year-old patient on long-term carbamazepine therapy for a seizure disorder ingests 10 grams of acetaminophen. How does the chronic use of carbamazepine affect this patient's risk profile for acetaminophen-induced hepatotoxicity?

  1. It decreases the risk by accelerating the non-toxic glucuronidation pathway of acetaminophen metabolism.
  2. It increases the risk by inducing CYP2E1, leading to a higher fraction of the dose being converted to NAPQI. (correct answer)
  3. It has no significant effect on the risk, as carbamazepine and acetaminophen are metabolized by different P450 isoenzymes.
  4. It decreases the risk by acutely competing with acetaminophen for metabolism, thereby slowing the formation of toxic metabolites.
Explanation: Carbamazepine, like phenytoin, rifampin, and chronic ethanol, is a well-known inducer of cytochrome P450 enzymes, including CYP2E1 and CYP3A4, which are involved in metabolizing acetaminophen to its toxic metabolite, NAPQI. Chronic therapy with these drugs upregulates the amount of enzyme available, meaning that for any given dose of acetaminophen, a larger proportion will be converted to NAPQI, leading to faster depletion of glutathione and an increased risk of hepatotoxicity. A is incorrect as carbamazepine does not primarily induce the glucuronidation pathway (UGT enzymes) for acetaminophen. C is incorrect because there is significant overlap in the metabolizing enzymes. D is incorrect as this describes acute competition, not the effect of chronic enzyme induction.

Question 9

A patient presents after a poly-substance overdose. Initial labs show a significant anion gap metabolic acidosis, concurrent respiratory alkalosis, and an AST of 150 U/L. The serum acetaminophen level is low, at 15 mcg/mL at 8 hours post-ingestion. Which of the following is the most likely explanation for the prominent acid-base disturbance?

  1. The metabolic acidosis is from lactic acidosis secondary to NAPQI-induced mitochondrial dysfunction.
  2. The laboratory results are likely erroneous due to interference from one of the ingested substances.
  3. The findings are consistent with alcoholic ketoacidosis from co-ingestion of ethanol.
  4. The acid-base picture is characteristic of a significant concomitant salicylate ingestion. (correct answer)
Explanation: When you encounter poly-substance overdoses with complex acid-base disturbances, focus on the characteristic patterns each toxin produces rather than getting distracted by seemingly contradictory findings. The combination of anion gap metabolic acidosis with concurrent respiratory alkalosis is pathognomonic for salicylate poisoning. Salicylates directly stimulate the respiratory center, causing hyperventilation and respiratory alkalosis as the primary effect. Simultaneously, they uncouple oxidative phosphorylation in mitochondria, leading to increased oxygen consumption, heat production, and ultimately metabolic acidosis with an elevated anion gap. This unique dual acid-base picture is virtually diagnostic of salicylate toxicity, making D correct. Choice A incorrectly attributes the findings to acetaminophen toxicity. While NAPQI can cause mitochondrial dysfunction, the acetaminophen level of 15 mcg/mL at 8 hours is well below toxic thresholds (>150 mcg/mL at 4 hours or >37 mcg/mL at 8 hours using the Rumack-Matthew nomogram). The elevated AST likely reflects early salicylate-induced hepatic effects, not acetaminophen toxicity. Choice B dismisses legitimate clinical findings. Laboratory interference is rare and shouldn't be assumed when the results form a coherent clinical picture. Choice C misinterprets the acid-base pattern. Alcoholic ketoacidosis typically presents with metabolic acidosis alone, not the distinctive mixed picture seen here. Additionally, respiratory alkalosis isn't characteristic of ethanol-related disorders. Remember: The combination of anion gap metabolic acidosis plus respiratory alkalosis should immediately trigger consideration of salicylate poisoning, regardless of what other substances may be involved in the overdose.

Question 10

A hospital's pharmacy is experiencing a shortage of intravenous N-acetylcysteine (NAC). A patient with acetaminophen toxicity requires treatment, and the oral formulation is available. Which of the following is a key consideration when using the 72-hour oral NAC protocol compared to the 21-hour IV protocol?

  1. The oral protocol is significantly less effective than the IV protocol, especially in cases of fulminant hepatic failure.
  2. Oral NAC is associated with a higher incidence of rate-related, non-allergic anaphylactoid reactions.
  3. The oral protocol requires a larger total cumulative dose of NAC and is frequently limited by gastrointestinal intolerance. (correct answer)
  4. The efficacy of oral NAC is significantly reduced by prior administration of activated charcoal, which binds the antidote.
Explanation: The 72-hour oral NAC protocol involves a loading dose of 140 mg/kg followed by 17 maintenance doses of 70 mg/kg every 4 hours. This results in a much larger total dose than the IV protocol and a longer treatment duration. A major limitation is its poor palatability and high incidence of nausea and vomiting, which can lead to incomplete dosing and treatment failure. A is incorrect because oral and IV NAC are considered equally effective if the full course is completed and tolerated, although IV is preferred in fulminant hepatic failure because of vomiting and altered mental status. B is incorrect because anaphylactoid reactions are a known complication of IV NAC, not oral NAC. D is incorrect because while there is a theoretical interaction between charcoal and oral NAC, clinical studies have not shown this to be significant, and the benefits of each treatment (charcoal early, NAC later) outweigh this concern.

Question 11

A 45-year-old male with a history of chronic alcohol use disorder presents after ingesting 15 grams of acetaminophen 6 hours ago. He states he has not consumed any alcohol in the past 48 hours. Which of the following best explains why this patient is at an increased risk for severe hepatotoxicity compared to a non-drinker?

  1. Chronic alcohol use induces CYP2E1, leading to increased production of the toxic metabolite, NAPQI. (correct answer)
  2. Acute abstinence from alcohol enhances the glucuronidation pathway, shunting more acetaminophen towards toxic metabolite formation.
  3. Chronic alcohol use directly depletes baseline glutathione stores, reducing the capacity to neutralize NAPQI.
  4. Alcohol and acetaminophen compete for metabolism by CYP2E1, leading to a delayed but more pronounced peak of NAPQI.
Explanation: Chronic alcohol consumption is a potent inducer of the cytochrome P450 isoenzyme CYP2E1. This enzyme is responsible for converting a small fraction of acetaminophen into its toxic metabolite, N-acetyl-p-benzoquinone imine (NAPQI). In a state of chronic induction, a larger proportion of an acetaminophen dose is shunted down this pathway, leading to increased NAPQI production and a higher risk of hepatotoxicity once glutathione stores are depleted. B is incorrect because glucuronidation is a safe, non-toxic metabolic pathway for acetaminophen; enhancing it would be protective, not harmful. C is incorrect because while malnutrition associated with chronic alcoholism can lead to lower glutathione stores, the primary mechanism of increased risk from chronic alcohol use itself is enzyme induction. D is incorrect as it describes the effect of acute alcohol ingestion, where competition for CYP2E1 can be transiently protective by slowing NAPQI formation. This patient has not had alcohol recently, so the induced state of the enzyme is the dominant effect.

Question 12

A 28-year-old patient is on day 2 of treatment with IV N-acetylcysteine for a massive acetaminophen overdose. Today's labs show: AST 8,500 U/L, ALT 9,200 U/L, Total Bilirubin 4.5 mg/dL, INR 3.8, and Creatinine 2.1 mg/dL. The patient is showing signs of Stage III encephalopathy. Which of the following is the most critical prognostic indicator in this patient and a key criterion for liver transplant evaluation?

  1. The peak AST/ALT levels, as they directly correlate with the degree of hepatocellular necrosis.
  2. The INR, as it reflects the failure of hepatic synthetic function for clotting factors. (correct answer)
  3. The total bilirubin, as it indicates the liver's failing excretory and metabolic capacity.
  4. The creatinine, as hepatorenal syndrome is a common and severe complication of liver failure.
Explanation: In acute liver failure (ALF), the International Normalized Ratio (INR) is one of the most critical prognostic indicators because it reflects the liver's ability to synthesize clotting factors, a key function that is rapidly lost in severe injury. An INR > 1.5 is a marker of significant hepatic dysfunction. In the context of acetaminophen-induced ALF, an arterial pH < 7.30 or the combination of an INR > 6.5, creatinine > 3.4 mg/dL, and Grade III/IV encephalopathy (King's College Criteria) indicates a poor prognosis and is an indication for urgent liver transplant evaluation. While all the listed labs are abnormal and concerning, the INR is the most direct measure of failing synthetic function and central to transplant criteria. A is incorrect because while transaminases indicate the extent of necrosis, their absolute peak value does not correlate well with prognosis; function is more important than the degree of enzyme release. C and D are incorrect because while elevated bilirubin and creatinine are also poor prognostic markers and part of the King's College Criteria, the INR is the most sensitive indicator of the liver's immediate synthetic capability.

Question 13

Fifteen minutes into the initial loading dose of an IV N-acetylcysteine infusion, a 22-year-old female develops flushing, pruritus, and mild urticaria. Her blood pressure and oxygen saturation remain stable. What is the most appropriate immediate action?

  1. Immediately and permanently discontinue the NAC infusion and switch to the oral formulation.
  2. Administer intramuscular epinephrine for presumed anaphylactic shock.
  3. Temporarily stop the infusion, administer diphenhydramine, and restart the infusion at a slower rate once symptoms resolve. (correct answer)
  4. Continue the infusion at the current rate but administer IV corticosteroids to prevent worsening of the reaction.
Explanation: The patient is experiencing a mild, non-IgE-mediated anaphylactoid reaction to the IV NAC infusion, which is common and related to the rate of infusion. Standard management for such a mild reaction (no hypotension or bronchospasm) is to temporarily pause the infusion, treat the symptoms with an H1-antagonist like diphenhydramine, and once the symptoms subside, resume the infusion at a slower rate (e.g., over 2 hours instead of 1). A is incorrect because the reaction is typically manageable, and permanently stopping a life-saving therapy is not warranted. B is incorrect because this is an overly aggressive response for a mild reaction without hemodynamic compromise; epinephrine is reserved for true anaphylaxis or severe anaphylactoid reactions. D is incorrect because the infusion should be stopped to reduce the causative stimulus, and antihistamines are the first-line treatment, not corticosteroids.

Question 14

A 55-year-old male with chronic back pain reports taking 8 to 10 tablets of acetaminophen 500 mg daily for the past 4 days. He now presents with nausea and right upper quadrant pain. His serum acetaminophen level is 25 mcg/mL, and his AST is 150 U/L. Which of the following is the most appropriate management strategy?

  1. Apply the Rumack-Matthew nomogram to the serum level to determine the need for N-acetylcysteine.
  2. Administer N-acetylcysteine due to the history of excessive ingestion and evidence of hepatotoxicity. (correct answer)
  3. Discharge the patient with instructions to stop acetaminophen, as the serum level is non-toxic.
  4. Administer activated charcoal and observe, as the total ingested dose is likely sub-toxic.
Explanation: The patient has a history of repeated, supratherapeutic ingestion of acetaminophen (4-5 g/day for 4 days) and now presents with symptoms (nausea, RUQ pain) and laboratory evidence (elevated AST) of liver injury. In cases of chronic or staggered overdose, the Rumack-Matthew nomogram is not applicable. The current recommendation is to initiate N-acetylcysteine (NAC) if there is evidence of hepatotoxicity (elevated aminotransferases) and a history of excessive ingestion. A is incorrect because the nomogram is only validated for single, acute ingestions where the time of ingestion is known. C is incorrect because even a 'non-toxic' level on the nomogram is meaningless in this context, and the elevated AST clearly indicates that hepatic injury is occurring. D is incorrect because activated charcoal is not effective for ingestions that have occurred over several days, and the dose is clearly in the potentially toxic range.

Question 15

A 30-year-old female who is 28 weeks pregnant presents 5 hours after an intentional acetaminophen overdose. Her serum level plots above the treatment line on the Rumack-Matthew nomogram. There is concern about potential risks of N-acetylcysteine (NAC) to the fetus. What is the most accurate statement regarding the management of this patient?

  1. NAC is a pregnancy Category X drug due to known teratogenicity, so only supportive care should be provided.
  2. The standard dose of NAC should be reduced by 50% to minimize fetal exposure while providing some maternal benefit.
  3. NAC should be administered promptly at the standard dose, as it crosses the placenta and is considered beneficial for the fetus. (correct answer)
  4. Treatment with NAC should be delayed until after emergent delivery to avoid any potential risk to the fetus.
Explanation: Acetaminophen toxicity is a medical emergency in a pregnant patient, as both the mother and fetus are at risk for hepatic failure. N-acetylcysteine (NAC) is pregnancy Category B and is the standard of care. It should be administered promptly at the usual weight-based dose. NAC crosses the placenta and is believed to directly treat the fetus, which also has the capacity to form toxic acetaminophen metabolites. The benefits of treating the mother and fetus far outweigh any theoretical risks of NAC. A is incorrect because NAC is Category B, not X, and is strongly indicated. B is incorrect because dose reduction is not recommended and would lead to undertreatment of both patients. D is incorrect because delaying treatment would be catastrophic for the mother and fetus; there is no indication for delivery, and treatment should begin immediately.

Question 16

A 35-year-old patient on long-term carbamazepine therapy for a seizure disorder ingests 10 grams of acetaminophen. How does the chronic use of carbamazepine affect this patient's risk profile for acetaminophen-induced hepatotoxicity?

  1. It decreases the risk by accelerating the non-toxic glucuronidation pathway of acetaminophen metabolism.
  2. It increases the risk by inducing CYP2E1, leading to a higher fraction of the dose being converted to NAPQI. (correct answer)
  3. It has no significant effect on the risk, as carbamazepine and acetaminophen are metabolized by different P450 isoenzymes.
  4. It decreases the risk by acutely competing with acetaminophen for metabolism, thereby slowing the formation of toxic metabolites.
Explanation: Carbamazepine, like phenytoin, rifampin, and chronic ethanol, is a well-known inducer of cytochrome P450 enzymes, including CYP2E1 and CYP3A4, which are involved in metabolizing acetaminophen to its toxic metabolite, NAPQI. Chronic therapy with these drugs upregulates the amount of enzyme available, meaning that for any given dose of acetaminophen, a larger proportion will be converted to NAPQI, leading to faster depletion of glutathione and an increased risk of hepatotoxicity. A is incorrect as carbamazepine does not primarily induce the glucuronidation pathway (UGT enzymes) for acetaminophen. C is incorrect because there is significant overlap in the metabolizing enzymes. D is incorrect as this describes acute competition, not the effect of chronic enzyme induction.

Question 17

A 21-year-old college student presents to the ED after ingesting 12 grams of acetaminophen simultaneously with a large quantity of vodka 4 hours ago. His blood alcohol level is 250 mg/dL. Compared to a patient who took the same dose of acetaminophen without alcohol, how does the acute co-ingestion of ethanol theoretically affect the initial phase of toxicity?

  1. It markedly increases NAPQI formation due to synergistic induction of the CYP2E1 enzyme.
  2. It accelerates the renal clearance of acetaminophen, lowering the total drug exposure.
  3. It rapidly depletes hepatic glutathione stores, increasing susceptibility to NAPQI-induced injury.
  4. It competitively inhibits CYP2E1, potentially reducing the initial peak of NAPQI formation. (correct answer)
Explanation: When you encounter acetaminophen toxicity questions involving alcohol co-ingestion, focus on the competing metabolic pathways and the concept of competitive inhibition versus chronic induction effects. Acetaminophen toxicity occurs when the normal conjugation pathways (glucuronidation and sulfation) become saturated, forcing more drug through the CYP2E1 pathway to form the toxic metabolite NAPQI. The key insight here is distinguishing between acute alcohol effects versus chronic alcohol exposure. In acute alcohol intoxication (like this scenario), ethanol and acetaminophen compete for the same enzyme system - CYP2E1. Since both substrates are present simultaneously at high concentrations, ethanol acts as a competitive inhibitor, reducing the immediate conversion of acetaminophen to NAPQI. This makes option D correct - the acute co-ingestion competitively inhibits CYP2E1, potentially reducing initial NAPQI formation. Option A is wrong because synergistic CYP2E1 induction occurs with chronic alcohol use over weeks, not acute intoxication. Option B incorrectly suggests renal mechanisms are the primary concern - acetaminophen toxicity is hepatic, and alcohol doesn't significantly enhance renal clearance. Option C confuses the timeline - while alcohol can affect glutathione stores, the immediate competitive inhibition effect on NAPQI formation is more relevant in the acute phase than glutathione depletion. Remember: acute alcohol = competitive inhibition (protective initially), chronic alcohol = enzyme induction (increased toxicity risk). This distinction frequently appears on pharmacology exams when testing drug interaction mechanisms.

Question 18

A 40-year-old male presents to the emergency department exactly 3 hours after ingesting approximately 20 grams of acetaminophen in a suicide attempt. He is awake and alert. An IV line is being placed for blood draws and potential N-acetylcysteine administration. Which of the following interventions is also indicated at this time?

  1. Administration of a single dose of activated charcoal. (correct answer)
  2. Immediate gastric lavage to remove any undissolved tablets from the stomach.
  3. Administration of sodium bicarbonate to alkalinize the urine and enhance elimination.
  4. Whole bowel irrigation due to the massive size of the reported ingestion.
Explanation: Activated charcoal is effective at adsorbing drugs within the gastrointestinal tract, preventing their absorption. Its use is most beneficial when administered within 1-2 hours of ingestion, but it can be considered up to 4 hours post-ingestion, especially for large overdoses where absorption may be slowed. Since this patient presents at 3 hours after a massive ingestion and has a protected airway (awake and alert), administration of activated charcoal is appropriate to reduce the total drug burden. B is incorrect because gastric lavage is rarely performed in modern toxicology as it is invasive and has not been shown to be superior to activated charcoal. C is incorrect as urinary alkalinization is a treatment for other poisonings, like salicylates or phenobarbital, but is not effective for acetaminophen. D is incorrect as whole bowel irrigation is used for substances not well adsorbed by charcoal, such as iron, lithium, or sustained-release products, not for immediate-release acetaminophen.

Question 19

A 33-year-old female is found unconscious with an empty bottle of acetaminophen next to her. The time of ingestion is unknown. On presentation to the ED, her labs show an AST of 450 U/L and an ALT of 510 U/L. A serum acetaminophen level is pending. What is the most appropriate immediate action regarding N-acetylcysteine (NAC)?

  1. Withhold NAC until the acetaminophen level returns to accurately plot it on the nomogram.
  2. Defer treatment, as the AST/ALT elevation could be from another cause such as viral hepatitis.
  3. Administer a half-dose of NAC and await the acetaminophen level to decide on the full dose.
  4. Administer NAC immediately without waiting for the acetaminophen level. (correct answer)
Explanation: When you encounter a potential acetaminophen overdose with unknown timing and evidence of hepatotoxicity, the priority is immediate antidotal therapy. Acetaminophen poisoning follows a predictable timeline where hepatic damage becomes irreversible if treatment is delayed beyond 8-10 hours post-ingestion. The correct approach is D) Administer NAC immediately without waiting for the acetaminophen level. This patient presents with clear signs of acetaminophen-induced hepatotoxicity (elevated AST/ALT) and unknown ingestion time, making her a candidate for empirical NAC therapy. NAC works by replenishing glutathione stores and providing an alternative pathway for acetaminophen metabolism, but its effectiveness diminishes significantly with delayed administration. Option A is wrong because waiting for lab results wastes precious time when hepatocyte death may be progressing. The Rumack-Matthew nomogram is only valid for acute ingestions with known timing within 24 hours. Option B incorrectly suggests deferring treatment when the clinical picture strongly suggests acetaminophen toxicity—other causes can be investigated while providing potentially life-saving therapy. Option C represents a dangerous compromise that provides inadequate antidotal effect while still delaying optimal treatment. Remember this key principle for acetaminophen overdose management: when in doubt, treat immediately. NAC has an excellent safety profile with minimal adverse effects, making the risk-benefit ratio heavily favor early administration. The mantra "time is hepatocytes" should guide your thinking—never let uncertainty about timing or levels delay NAC in patients with evidence of acetaminophen-induced liver injury.

Question 20

A patient presents after a poly-substance overdose. Initial labs show a significant anion gap metabolic acidosis, concurrent respiratory alkalosis, and an AST of 150 U/L. The serum acetaminophen level is low, at 15 mcg/mL at 8 hours post-ingestion. Which of the following is the most likely explanation for the prominent acid-base disturbance?

  1. The metabolic acidosis is from lactic acidosis secondary to NAPQI-induced mitochondrial dysfunction.
  2. The laboratory results are likely erroneous due to interference from one of the ingested substances.
  3. The findings are consistent with alcoholic ketoacidosis from co-ingestion of ethanol.
  4. The acid-base picture is characteristic of a significant concomitant salicylate ingestion. (correct answer)
Explanation: When you encounter poly-substance overdoses with complex acid-base disturbances, focus on the characteristic patterns each toxin produces rather than getting distracted by seemingly contradictory findings. The combination of anion gap metabolic acidosis with concurrent respiratory alkalosis is pathognomonic for salicylate poisoning. Salicylates directly stimulate the respiratory center, causing hyperventilation and respiratory alkalosis as the primary effect. Simultaneously, they uncouple oxidative phosphorylation in mitochondria, leading to increased oxygen consumption, heat production, and ultimately metabolic acidosis with an elevated anion gap. This unique dual acid-base picture is virtually diagnostic of salicylate toxicity, making D correct. Choice A incorrectly attributes the findings to acetaminophen toxicity. While NAPQI can cause mitochondrial dysfunction, the acetaminophen level of 15 mcg/mL at 8 hours is well below toxic thresholds (>150 mcg/mL at 4 hours or >37 mcg/mL at 8 hours using the Rumack-Matthew nomogram). The elevated AST likely reflects early salicylate-induced hepatic effects, not acetaminophen toxicity. Choice B dismisses legitimate clinical findings. Laboratory interference is rare and shouldn't be assumed when the results form a coherent clinical picture. Choice C misinterprets the acid-base pattern. Alcoholic ketoacidosis typically presents with metabolic acidosis alone, not the distinctive mixed picture seen here. Additionally, respiratory alkalosis isn't characteristic of ethanol-related disorders. Remember: The combination of anion gap metabolic acidosis plus respiratory alkalosis should immediately trigger consideration of salicylate poisoning, regardless of what other substances may be involved in the overdose.